Glaukos Corporation reposted this
Glaukos has seen many exciting updates, including the FDA approval of iDose® TR (travoprost intracameral implant) 75 mcg, our groundbreaking solution for glaucoma care that helps manage eye pressure by releasing medication continuously. While Glaukos is constantly growing, our commitment to a people-centered culture remains the same. Join us in shaping the future of eye care: https://bit.ly/44sJLS5 #Glaukos Find out more about iDose® TR: https://lnkd.in/e9nbQ_q9 May cause increases in intraocular pressure, iritis, and dry eye. Visit https://bit.ly/iDoseTR_PI for full Prescribing Information.